These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30318577)

  • 1. Does endocan level increase in women with polycystic ovary syndrome? A case - control study.
    Delibas IB; Yapca OE; Laloglu E
    Ginekol Pol; 2018; 89(9):500-505. PubMed ID: 30318577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated PAPP-A levels in lean patients with polycystic ovary syndrome.
    Öztürk M; Öktem M; Altinkaya SÖ; Öktem EÖ; Elbeg Ş; Erdem A; Erdem M
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):394-398. PubMed ID: 29880172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum endocan concentration in women with pre-eclampsia.
    Yuksel MA; Tuten A; Oncul M; Acikgoz AS; Temel Yuksel I; Toprak MS; Ekmekci H; Balci Ekmekci O; Madazli R
    Arch Gynecol Obstet; 2015 Jul; 292(1):69-73. PubMed ID: 25534164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome.
    Deveer R; Engin-Üstün Y; Uysal S; Su FA; Sarıaslan S; Gülerman C; Mollamahmutoğlu L
    Gynecol Endocrinol; 2012 Aug; 28(8):602-5. PubMed ID: 22316276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat.
    Elkamshoushi AM; Omar SS; El Abd AM; Hassan SZ; Sultan EA; Abd Elkawy E
    Int J Dermatol; 2019 Apr; 58(4):456-464. PubMed ID: 30471086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are progranulin levels associated with polycystic ovary syndrome and its possible metabolic effects in adolescents and young women?
    Ersoy AO; Tokmak A; Ozler S; Oztas E; Ersoy E; Celik HT; Erdamar H; Yilmaz N
    Arch Gynecol Obstet; 2016 Aug; 294(2):403-9. PubMed ID: 27071619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between red blood cell distribution width and polycystic ovary syndrome.
    Yilmaz Ö; Mehmet C; Kelekci S; Temur M
    Endocr Res; 2015; 40(4):181-7. PubMed ID: 25531764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
    Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
    Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of endocan correlate with the presence and severity of pre-eclampsia.
    Cakmak M; Yilmaz H; Bağlar E; Darcin T; Inan O; Aktas A; Celik HT; Ozdemir O; Atalay CR; Akcay A
    Clin Exp Hypertens; 2016; 38(2):137-42. PubMed ID: 26418319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A; Cure E; Cure MC; Uslu AU; Balta S; Mikhailidis DP; Ozturk C; Arslan S; Sakız D; Sahin M; Kucuk A
    Angiology; 2016 Sep; 67(8):749-55. PubMed ID: 26614790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
    Barcellos CR; Rocha MP; Hayashida SA; Dantas WS; Dos Reis Vieira Yance V; Marcondes JA
    Hormones (Athens); 2015; 14(2):251-7. PubMed ID: 26158655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
    Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
    Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.